Company Filing History:
Years Active: 2012
Title: Yan Wang: Innovator in Pharmaceutical Compositions
Introduction
Yan Wang is a notable inventor based in Redwood City, CA, who has made significant contributions to the field of pharmaceutical compositions. With a total of 2 patents, his work focuses on innovative treatments for arthritis and cardiac conditions.
Latest Patents
Yan Wang's latest patents include compositions for treating arthritis that comprise the HG1023575 polypeptide. This invention provides pharmaceutical polypeptide compositions that promote proteoglycan synthesis and enhance the activity of chondrocyte cells, thereby offering a potential treatment for arthritis. Additionally, he has developed compositions that include FGF-9 and betacellulin, which are aimed at treating cardiac conditions. These pharmaceutical polypeptide compositions promote the survival of cardiac cells, recruit them to the cardiac area, and stimulate their differentiation and proliferation. Methods for delivering these compositions include catheterization and direct injection, utilizing various growth factors to enhance their effectiveness.
Career Highlights
Yan Wang is currently associated with Five Prime Therapeutics, Inc., where he continues to innovate in the pharmaceutical field. His work has the potential to significantly impact the treatment of chronic conditions, improving the quality of life for many patients.
Collaborations
He collaborates with esteemed colleagues, including Lewis T. Williams and Hongbing Zhang, who contribute to the advancement of his research and inventions.
Conclusion
Yan Wang's contributions to pharmaceutical compositions demonstrate his commitment to addressing critical health issues through innovation. His patents reflect a dedication to improving treatment options for arthritis and cardiac conditions, showcasing the importance of research and development in the medical field.